In-Ho Chae

Showing 1-3 of 3 articles

Author Min Gyu Kong

Coronary interventions

Clinical outcomes of long stent in the drug-eluting stent era: patient-level pooled analysis from the GRAND-DES registry

Kong MG, Han J-K, Kang J, Zheng C, Yang H, Park K, Kang H-J, Koo B, Chae I, Kim H, Choi YJ, Shin E, Bae J-W, Chun K-J, Kim D, Rha S, Lee S, Rhew JY, Woo S-I, Lee HC, Jeong J-O

September 24, 2019 | 10.4244/EIJ-D-19-00296

Author Si-Hyuck Kang

Stents and scaffolds

Long-term safety of bioresorbable scaffolds: insights from a network meta-analysis including 91 trials

Kang S, Gogas B, Jeon K, Park J-S, Lee W, Yoon C, Suh J-W, Hwang S-S, Youn T, Chae I, Kim H

March 20, 2018 | 10.4244/EIJ-D-17-00646

Author Si-Hyuck Kang

Coronary interventions

Angiographic outcomes of Orsiro biodegradable polymer sirolimus-eluting stents and Resolute Integrity durable polymer zotarolimus-eluting stents: results of the ORIENT trial

Kang S, Chung W-Y, Lee J, Park J-J, Yoon C, Suh J-W, Cho Y-S, Doh J, Cho J, Bae J-W, Youn T, Chae I

January 20, 2017 | 10.4244/EIJ-D-16-00179

1

Latest news

Antiplatelet strategies for complex PCI, are all DES equal at 10-year follow-up? cost-effectiveness of TAVR…find all the answers in the new issue

(Intravascular lithotripsy (3.5 mm Shockwave; left), followed by balloon dilatation (4.0 mm NC; right))

December 6, 2019

Discover 5 new trials: GALILEO, CONDI-2/ERIC-PCI, EVOLUTE II-5 years, SCOPE and Excel 5 years

(The Trials book is supported by Biotronik)

December 13, 2019

New this week: A Dose-response Meta Analysis, stroke after MitraClip and more

December 10, 2019

The challenge of innovation for the (interventional?) cardiology world

December 6, 2019

Guidance Papers

Guidelines, consensus & position papers

2019 – A leap year for valvular heart disease

(Course directors PCR London Valves 2019)

November 15, 2019

Last week's JAA's: EXTREME Study, Stent Optimization and more

December 3, 2019

Coronary

Valvular disease

Heart failure

Peripheral

Hypertension

Stroke